The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas
Open Access
- 13 August 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 123 (8) , 1761-1769
Abstract
Ovarian epithelial carcinomas (OECs) frequently exhibit amplifications at the 20q13 locus which is the site of several oncogenes, including the eukaryotic elongation factor EEF1A2 and the transcription factor ZNF217. We reported previously that overexpressed ZNF217 induces neoplastic characteristics in precursor cells of OEC. Unexpectedly, ZNF217, which is a transcriptional repressor, enhanced expression of eEF1A2. In our study, array comparative genomic hybridization, single nucleotide polymorphism and Affymetrix analysis of ZNF217‐overexpressing cell lines confirmed consistently increased expression of eEF1A2 but not of other oncogenes, and revealed early changes in EEF1A2 gene copy numbers and increased expression at crisis during immortalization. We defined the influence of eEF1A2 overexpression on immortalized ovarian surface epithelial cells, and investigated interrelationships between effects of ZNF217 and eEF1A2 on cellular phenotypes. Lentivirally induced eEF1A2 overexpression caused delayed crisis, apoptosis resistance and increases in serum‐independence, saturation densities and anchorage independence. siRNA to eEF1A2 reversed apoptosis resistance and reduced anchorage independence in eEF1A2‐overexpressing lines. Remarkably, siRNA to eEF1A2 was equally efficient in inhibiting both anchorage independence and resistance to apoptosis conferred by ZNF217 overexpression. Our data define neoplastic properties that are caused by eEF1A2 in nontumorigenic ovarian cancer precursor cells, and suggest that eEF1A2 plays a role in mediating ZNF217‐induced neoplastic progression. Published 2008 Wiley‐Liss, Inc.Keywords
This publication has 27 references indexed in Scilit:
- Telomere dysfunction, genome instability and cancerFrontiers in Bioscience-Landmark, 2008
- Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesisCancer Genetics and Cytogenetics, 2003
- Differentially Regulated Genes as Putative Targets of Amplifications at 20q in Ovarian CancersJapanese Journal of Cancer Research, 2002
- Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancerNature Genetics, 2002
- Peptide Elongation Factor eEF1A-2/S1 Expression in Cultured Differentiated Myotubes and Its Protective Effect against Caspase- 3-mediated ApoptosisJournal of Biological Chemistry, 2002
- Moonlighting Functions of Polypeptide Elongation Factor 1: From Actin Bundling to Zinc Finger Protein R1-Associated Nuclear LocalizationBioscience, Biotechnology, and Biochemistry, 2002
- The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells.2001
- Interaction of ZPR1 with Translation Elongation Factor-1α in Proliferating CellsJournal of Cell Biology, 1998
- Elongation factor 1α, translation and the cytoskeletonTrends in Biochemical Sciences, 1995
- Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrixAmerican Journal of Obstetrics and Gynecology, 1992